Lazard Asset Management Portfolio holdings
AUM
$72.7B
This Quarter Return
+1.83%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$44.8B
AUM Growth
+$44.8B
(-0.63%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
17.23%
Holding
1,160
New
109
Increased
257
Reduced
356
Closed
112
Top Buys
| 1 |
Eli Lilly
LLY
|
$361M |
| 2 |
CEMIG Preferred Shares
CIG
|
$249M |
| 3 |
Mastercard
MA
|
$182M |
| 4 |
Kellanova
K
|
$173M |
| 5 |
IQVIA
IQV
|
$159M |
Top Sells
| 1 |
Televisa
TV
|
$382M |
| 2 |
Walmart
WMT
|
$189M |
| 3 |
Chevron
CVX
|
$157M |
| 4 |
AbbVie
ABBV
|
$153M |
| 5 |
Citigroup
C
|
$148M |
Sector Composition
| 1 | Healthcare | 15.67% |
| 2 | Technology | 12.91% |
| 3 | Communication Services | 12.84% |
| 4 | Financials | 10.62% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Honeywell
HON
$139B
| $402M | 0.9% | 4,335,990 -198,658 | -4% | -$18.4M |
|
|
27
Chevron
CVX
$324B
| $399M | 0.89% | 3,356,264 -1,316,390 | -28% | -$157M |
|
|
TYC
28
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $390M | 0.87% | 9,207,998 +2,334,426 | +34% | +$99M |
|
29
Baxter International
BAX
$12.7B
| $389M | 0.87% | 5,293,477 -125,795 | -2% | -$9.26M |
|
30
American Express
AXP
$231B
| $384M | 0.86% | 4,269,648 -583,615 | -12% | -$52.5M |
|
|
31
Eli Lilly
LLY
$657B
| $379M | 0.85% | 6,445,812 +6,135,971 | +1,980% | +$361M |
|
32
APA Corp
APA
$8.31B
| $379M | 0.85% | 4,573,360 +41,812 | +0.9% | +$3.47M |
|
|
33
Citigroup
C
$178B
| $373M | 0.83% | 7,841,167 -3,100,094 | -28% | -$148M |
|
34
Sysco
SYY
$38.5B
| $362M | 0.81% | 10,006,048 +4,342,281 | +77% | +$157M |
|
|
MON
35
DELISTED
Monsanto Co
MON
| $348M | 0.78% | 3,054,790 -231,766 | -7% | -$26.4M |
|
36
Oracle
ORCL
$635B
| $347M | 0.78% | 8,488,622 -717,316 | -8% | -$29.3M |
|
37
SPDR S&P 500 ETF Trust
SPY
$658B
| $341M | 0.76% | 1,820,591 +764,892 | +72% | +$143M |
|
38
CNX Resources
CNX
$4.13B
| $340M | 0.76% | 8,506,852 -142,484 | -2% | -$5.69M |
|
39
Amgen
AMGN
$155B
| $328M | 0.73% | 2,658,423 -265,126 | -9% | -$32.7M |
|
40
Exxon Mobil
XOM
$487B
| $305M | 0.68% | 3,122,156 -238,711 | -7% | -$23.3M |
|
|
CFN
41
DELISTED
CAREFUSION CORPORATION
CFN
| $293M | 0.66% | 7,290,188 -715,563 | -9% | -$28.8M |
|
42
Hartford Financial Services
HIG
$37.2B
| $291M | 0.65% | 8,245,267 +918,676 | +13% | +$32.4M |
|
43
Johnson & Johnson
JNJ
$427B
| $285M | 0.64% | 2,902,663 -621,838 | -18% | -$61.1M |
|
44
Bristol-Myers Squibb
BMY
$96B
| $279M | 0.62% | 5,372,906 -224,371 | -4% | -$11.7M |
|
45
Qualcomm
QCOM
$173B
| $277M | 0.62% | 3,514,735 -522,140 | -13% | -$41.2M |
|
46
Occidental Petroleum
OXY
$46.9B
| $274M | 0.61% | 2,875,062 -241,982 | -8% | -$23.1M |
|
47
Transocean
RIG
$2.86B
| $269M | 0.6% | 6,517,952 -2,102,393 | -24% | -$86.9M |
|
48
Intercontinental Exchange
ICE
$101B
| $268M | 0.6% | 1,352,609 +297,649 | +28% | +$58.9M |
|
49
PG&E
PCG
$33.6B
| $267M | 0.6% | 6,191,168 +2,629,284 | +74% | +$114M |
|
50
Teva Pharmaceuticals
TEVA
$21.1B
| $264M | 0.59% | 4,994,641 -369,884 | -7% | -$19.5M |
|